
ãæ·±å»ãªä¿¡é Œã®ä¹±çšãïŒãã¡ãŠãæ°ã®å åŽè¿ãCOVIDã®èµ·æºã«é¢ããæ¿åºèšé²ã®é èœå ±è¬ã§èµ·èšŽ
å èšäºã¯ãã¡ããã/Click here to read the original article.
2005幎ãã2025幎ãŸã§ç±³åœåœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶æïŒNIAIDïŒæé·å®€ã«åšç±ããŠãããã€ãããã»ã¢ãŒã¬ã³ã¹å士ã¯ãå ±è¬ãé£éŠææ»ã«ãããèšé²ã®ç Žæ£ãèšé²ã®é èœãå«ã5ã€ã®çœªã«çŽé¢ããŠããŸããã¢ã³ãœããŒã»ãã¡ãŠãå士ã¯2022幎12æã«éä»»ãããŸã§NIAIDãçããŠããŸããã
é£éŠå€§éªå¯©ã¯æ¬æ¥ãã¢ã³ãœããŒã»ãã¡ãŠãå士ã®å äžçŽé¡§åããæ°åã³ãããŠã€ã«ã¹ïŒCOVID-19ïŒã®èµ·æºã«é¢ããããåããé ãããã«ç§çšã¡ãŒã«ã¢ã«ãŠã³ãã䜿çšãããŠã€ã«ã¹ãç ç©¶æã§ã¯ãªãèªç¶ç±æ¥ã ãšããå ¬çãªç©èªã®åœ¢æã«é¢äžããçãã§èµ·èšŽããã
ãã€ãããã»ã¢ã¬ã³ãºå士ïŒ78ïŒã¯ã2006幎ãã2022幎ãŸã§åœç«ã¢ã¬ã«ã®ãŒã»ææçç ç©¶æïŒNIAIDïŒæé·å®€ã«å€åããŠãããå ±è¬ãé£éŠææ»ã«ãããèšé²ç Žæ£ãèšé²é å¿ãªã©5ä»¶ã®çœªã«åãããŠããããã¡ãŠãæ°ã¯2022幎12æã®éä»»ãŸã§NIAIDãçããŠããã
å眪ç¶ã«ã¯æé·5幎ãã20幎ã®çŠé®åãç§ãããå¯èœæ§ãããã
起蚎ç¶ã«ããã°ïŒ4æ16æ¥ä»ãã¡ãªãŒã©ã³ãå·ã®é£éŠè£å€æã§æææ¥ã«å ¬éïŒãã¢ã¬ã³ãºæ°ã¯é£éŠæ å ±å ¬éæ³ïŒFOIAïŒè«æ±ããéä¿¡èšé²ãå®ãããã«ç§çšã¡ãŒã«ã¢ã«ãŠã³ãã䜿ã£ãŠããã
起蚎ç¶ã«ã¯ãé£éŠèšé²ã®é å¿ã»ç Žæ£ã«ãããŠã¢ã¬ã³ãºæ°ãšå ±è¬ãããšããã身å äžè©³ã®å ±è¬è 2人ã®ååšãèšèŒãããŠããã
ãã©ãã¯ã¹ã»ãã¥ãŒã¹ã«ãããšãã¢ã¬ã³ãºæ°ãšä»ã®æ¿åºåœå±è ãšã®ã¡ãŒã«ã«ã¯ããCOVIDç ç©¶ã«é¢ããè°è«ãè³éé åã®æ±ºå®ã«åœ±é¿ãäžããããšããåãããããŠã€ã«ã¹ã®èµ·æºã«é¢ããã¡ãã»ãŒãžã®ãããšãããå«ãŸããŠãããšãããã
ãããã»ãã©ã³ã代çåžæ³é·å®ã¯ããããã®çæã¯ãäžççãªãã³ãããã¯ãæé«æœ®ã«éããã¢ã¡ãªã«åœæ°ãæãå¿ èŠãšããŠããææã«ãä¿¡é Œãæ·±ãè£åããã®ã ããšè¿°ã¹ãã
ãæ¿åºåœå±è ã¯ãå ¬çå©çã«å¥ä»ããããã«ãèª å®ã§æ ¹æ ã®ããäºå®ãšå©èšãæäŸããå³ç²ãªè²¬åãè² ã£ãŠããââèªãã®å人çãŸãã¯ã€ããªãã®ãŒçãªã¢ãžã§ã³ããæšãé²ããããã§ã¯ãªãããšãã©ã³ãæ°ã¯è¿°ã¹ãã
起蚎ç¶ã¯ã説åŸåã®ããã蚌æ ãæç€º
ç±³åžæ³çïŒDOJïŒã¯ãã¢ãŒã¬ã³ã¹ãå ±è¬è ããšååããäžåœã»æŠæŒ¢ãŠã€ã«ã¹ç ç©¶æã§å®æœããŠããã³ãŠã¢ãªç±æ¥ã³ãããŠã€ã«ã¹ç ç©¶ãžã®è³éæäŸãå埩ãããããšãããšäž»åŒµããŠãããç±³åœç«è¡çç ç©¶æïŒNIHïŒã¯å®å šæ§ãžã®æžå¿µãããã®è³éæäŸãæã¡åã£ãŠããã
å ±è¬è ã®1人ã¯ããããããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ã®å äŒé·ããŒã¿ãŒã»ãã¶ãã¯ïŒPh.D.ïŒã§ãããåå£äœã¯æŠæŒ¢ã®ç ç©¶æã§ã®ã³ãããŠã€ã«ã¹ç ç©¶ã«å¯ŸããŠNIHã®å©æéãåããŠããã
2024幎ãç±³ä¿å¥çŠç¥çïŒHHSïŒã¯ããªã¹ã¯ã®é«ãã³ãããŠã€ã«ã¹å®éšãé©åã«ç£ç£ã§ããŠããªãã£ããšããŠããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ãžã®ãã¹ãŠã®è³éæäŸã忢ããã
DOJã¯ãŸããã¢ãŒã¬ã³ã¹ãå ±èè ã®1人ããèŽãç©ãåãåã£ãŠãããšäž»åŒµããŠããããã®å ±èè ãšã¯ãCOVID-19ãã³ãããã¯ã®åå ã§ããSARS-CoV-2ãŠã€ã«ã¹ã«ã¯äººç£å ±éææïŒèªç¶ïŒèµ·æºããããšç€ºåããç§åŠè«æã§ã¢ãŒã¬ã³ã¹ãšååãã人ç©ã ã
ããã«ã¢ãŒã¬ã³ã¹ã¯ãå ±èè ããšã®é£çµ¡ããåŸãæ å ±ãNIAIDäžå±€éšã«äŒéããäžå±€éšã¯ãã®åŸãCOVID-19ãã³ãããã¯ã®æäžã«ãã¯ã€ãããŠã¹ãè°äŒããããŠåœæ°ã«èª¬æããŠãããšãåçã¯äž»åŒµããŠããã
ãéææ§ãåé¿ããæå³ã§èšé²ãããã³ã«ãè¿åããè¡çºã¯ãFBIãšããŠæ±ºããŠå®¹èªããªãããFBIé·å®ã«ã·ã»ããã«ã¯å£°æã§è¿°ã¹ãããã¢ãŒã¬ã³ã¹ã¯éæ³ãªéä¿¡åœè£ ã«é¢äžããçããããã ãã§ãªãããã®èŠè¿ããšããŠããã¯ããã¯ãåãåã£ãŠãããã
調æ»å ±éèšè ããŒã«ã»Dã»ãµãã«ãŒã¯ãã¢ãŒã¬ã³ã¹ã«é¢ãã詳现ãªå ±éãéããŠãã人ç©ã ããä»åã®èµ·èšŽããçŽ æŽãããç¬¬äžæ©ããšè©ãã€ã€ãã身å äžè©³ã®å ±è¬è ãå ¬ã«åæããããã®ãããŸããã®èµ·èšŽãä»ã®äººç©ãžã®èšŽè¿œã«ã€ãªããã®ãçåãåããã
ã©ãã¬ãŒã¹å€§åŠã®ååçç©åŠè ãªãã£ãŒãã»ãšãã©ã€ãïŒPh.D.ïŒã¯ãäºå®é¢ä¿ãããå¿åã®2人ã®å ±è¬è ã¯ãã¶ãã¯ãšãžã§ã©ã«ãã»ãã¥ãŒã·ã¥å»åž«ïŒNIHãã©ã¬ãã£åœéã»ã³ã¿ãŒå æé·ãåã»ã³ã¿ãŒã¯æµ·å€ã®ç§åŠè ãæ¯æŽïŒã§ããããšã瀺ããŠãããšè¿°ã¹ãã
ããã®3人ã«å¯Ÿãã蚌æ ã¯åŒ·åã ãããšãšãã©ã€ãã¯ãã¢ãŒã¬ã³ã¹ããã¶ãã¯ããã¥ãŒã·ã¥ãæããŠè¿°ã¹ããããã«åœŒã¯ãå 責ãšåŒãæãã«ãã¡ãŠãæ°ãä»ã®äººç©ã«äžå©ãªèšŒæ ãæäŸããè ã1人ã§ãçŸããªãéãã3äººå šå¡ãæçœªãšãªãã¹ãã§ããããããããããªãã ããããšèªã£ãã
COVID-19ã¯ã¯ãã³ã®æå®³äºè±¡è¢«å®³è ãæ¯æŽããå£äœReact19ã®æ³å責任è ã¯ãªã¹ããã¡ãŒã»ãã©ã€ã¹ãããã¯ããã¡ãŠãæ°ãNIHã«ææžãæ±ãããã®ã®å®ããªãã£ã被害è ããããšããä»åã®èµ·èšŽã¯ãæ¿åºé«å®ã«èª²ãããéææ§ãšããäžæ žç矩åãçªããã®ã ããšè¿°ã¹ãã
ãCOVIDã¯ã¯ãã³è¢«å®³è ã³ãã¥ããã£ã«ãšã£ãŠãããã¯äžå人ãäžã€ã®ä»®èª¬ã®åé¡ã§ã¯ãããŸãããæ¯é çãªãã©ãã£ãã«ç°è°ãå±ããæ å ±ãå ¬ã®æ€èšŒããé ãããäžæ¹ã§ãåããã©ãã£ããæ¢å®ã®äºå®ãšããŠæç€ºããããšãããã¿ãŒã³ã®åé¡ãªã®ã§ãããšãã©ã€ã¹ãããã¯èªã£ãã
åŒè·å£«ã°ã¬ãã°ã»ã°ã¬ã€ã¶ãŒã¯ãå ¬çãªCOVIDãã©ãã£ãã«çåãåããããšã§ãéããããããã¬ã¹ã©ã€ãã£ã³ã°ãåãããå®¶æã«ãšã£ãŠããã®èµ·èšŽã¯ããã ã«å ¥ã£ã巚倧ãªã²ã³ãã ãšè¿°ã¹ãããã ã圌ã¯ãããã¯ãå šç¶ååã§ã¯ãªãããšããŠããä»çµã¿å šäœãã«å¯Ÿãã調æ»ãæ±ããã
NIHãšNIAIDã®äžäœæ©é¢ã§ããç±³ä¿å¥çŠç¥çã¯ãã³ã¡ã³ããæ±ããã¶ã»ãã£ãã§ã³ããŒãDOJã«è»¢éãããDOJã®å ±éæ åœè ã¯ãä¿å±äžã®æ¡ä»¶ã§ãããšããŠã³ã¡ã³ããæ§ããã
ã¢ãŒã¬ã³ã¹ã¯COVID察å¿ãšãã³ãããã¯æã®å¯Ÿå€çºä¿¡ã§éèŠãªåœ¹å²
ãã¥ãŒãšãŒã¯ã»ãã¹ãçŽã¯ãã¢ãŒã¬ã³ã¹ãã2014幎ã«å§ãŸã£ãããšã³ãã«ã¹ã»ã¢ã©ã€ã¢ã³ã¹ãžã®NIHã®å©æéãç£ç£ããŠãããšå ±ããããã®å©æéã¯ãæçµçã«ãç±³åœã®çŽçšè è³éãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æïŒWIVïŒã®ã³ãŠã¢ãªã»ã³ãããŠã€ã«ã¹ç ç©¶ã«æµãçµæãšãªã£ããã
2024幎ã®è°äŒå ¬èŽäŒã§ãã¢ãŒã¬ã³ã¹ã¯ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æãžã®NIAID婿ã«é¢ããŠãã¡ãŠãæ°ãšåè°ããŠãããšèšŒèšããã
起蚎ç¶ã«ããã°ãããããåè°ã¯éèŠæ§ã垯ã³ãŠããããšããã®ããã¢ãŒã¬ã³ã¹ã¯æ¿åºã®COVID-19察å¿ãšããã³ãããã¯æã®å¯Ÿå€çã¡ãã»ãŒãžçºä¿¡ã«ãããŠéèŠãªåœ¹å²ãæ ã£ãŠããããã ãDOJã¯æ¬¡ã®ããã«è¿°ã¹ãŠããã
ãã¢ãŒã¬ã³ã¹ã¯ã婿å ãç§åŠã³ãã¥ããã£ã®é¢ä¿è ããæ å ±ãåéããCOVID-19ã®æ§è³ªã«é¢ããäºå®ã確ç«ãããããã«ãããã³ãããŠã€ã«ã¹ç ç©¶ã«ãããNIHããã³NIAIDã®éå»ã®åãçµã¿ãææ¡ããæ¿çãšæç¶ãã®çå®ãæ¯æŽããNIAIDäžçŽå¹¹éš1ãã¡ãŠãæ°ïŒœã«ããªãŒãã£ã³ã°ãè¡ããåæ°ãç±³åœå€§çµ±é ãè°äŒãåœæ°ã«æ å ±ãäŒããããããã«ãããã
DOJã¯ãåé¡ãšãªã£ããšã³ãã«ã¹ã®å©æéãã³ãŠã¢ãªã»ã³ãããŠã€ã«ã¹åºçŸãªã¹ã¯ã®çè§£ïŒUnderstanding the Risk of Bat Coronavirus EmergenceïŒãã¯ããCOVID-19ãæŠæŒ¢ãŠã€ã«ã¹ç ç©¶æããçºçãããšããç矩ã«åºã¥ããåãæ¶ããããšè¿°ã¹ãã
婿éã®æã¡åãã«ãããã¢ãŒã¬ã³ã¹ãšå ±è¬è ãã¯ãã³ãŠã¢ãªã»ã³ãããŠã€ã«ã¹å©æéã®æã¡åããèŠããCOVID-19ãç ç©¶æããæŒãããããšãããã©ãã£ãã«å¯Ÿæãããããšããã
ããããã®æ¡ä»¶ã¯ãã¹ãŠãäžçŽé¡§åãšããŠã®ã¢ãŒã¬ã³ã¹ã®è·åç¯å²ã«å«ãŸããæ¿åºã·ã¹ãã äžã§äœæã»ç¶æã»äº€æãããã¹ãé£éŠèšé²ã«è©²åœããããšDOJã¯è¿°ã¹ãã
DOJã«ãããšãå ±è¬è ã®1人ã¯ãã¢ãŒã¬ã³ã¹ã®ãèå°è£ã®è¶çªããžã®è¬ç€ŒãšããŠã¯ã€ã³ãèŽã£ãããããšã¢ãŒã¬ã³ã¹ã¯ããã®èŽãç©ã«ãå€ãããå ¬çè¡çºãšããŠãèªããå®è¡å¯èœãªãã®ãç¹å®ãããããã¯ãCOVID-19ã«èªç¶èµ·æºããããšäž»åŒµãããèåå»åŠèªã§ã®ç§åŠçã³ã¡ã³ã¿ãªãŒã ã£ãã
2024幎ã«å ¬éãããã¢ãŒã¬ã³ã¹ã®é»åã¡ãŒã«ã«ã¯ãé£éŠæ³ãåé¿ããåä¿¡ç®±ããæœåšçãªã決å®ç蚌æ ããåé€ã§ãããšèªç€ºããŠããããã«èŠããè€æ°ã®èšè¿°ãå«ãŸããŠããã
ãFOIAã®ïŒœå¿é ã¯ãããŸããããããŒïŒ»ãã¡ãŠãã«ã¯åœŒã®ç§çšGmailã«éãããè·å Žãèªå® ã§ææž¡ãããšãã§ããŸããããšã2021幎4æ21æ¥ä»ã®ã¡ãŒã«ã§ã¢ãŒã¬ã³ã¹ã¯æžããïŒãã¹ãçŽåŒçšïŒãã圌ã¯ãé¢åäºãæãå¯èœæ§ã®ãããã®ãååã«éãããªãã»ã©è³¢æã§ããã
2021幎2æ24æ¥ä»ã®ã¡ãŒã«ã§ã¯ãã¢ãŒã¬ã³ã¹ã¯ããèšãããããã¡ãã®FOIAæ åœã®å¥³æ§ãããFOIAãåããåŸã§ãæ€çŽ¢ãå§ãŸãåã«ã¡ãŒã«ãæ¶ãæ¹æ³ãåŠã³ãŸãããããã«ã以åã®ã¡ãŒã«ã®å€§åã¯Gmailã«éã£ãåŸã§åé€ããŸãããã
2021幎9æ9æ¥ä»ã®ã¡ãŒã«ã§ã¯ãã¢ãŒã¬ã³ã¹ã¯ãNIHã®ã¡ãŒã«ã¯åžžã«FOIAã®å¯Ÿè±¡ã«ãªãããããã€ãGmailã§é£çµ¡ããããšæžãããããã«ããã¥ãŒãšãŒã¯ã»ã¿ã€ã ãºã§èŠãããªããã®ã¯äœã§ãåé€ããããšãè¿°ã¹ãŠããã
ãããã®ææžã¯ãŸããã¢ãŒã¬ã³ã¹ãNIAIDã«ãããŠã2011幎ã®ãé«ç åæ§ãé³¥ã€ã³ãã«ãšã³ã¶ã«é¢ããç©è°ãéžããå®éšãªã©ãæ©èœç²åŸïŒã²ã€ã³ã»ãªãã»ãã¡ã³ã¯ã·ã§ã³ïŒå®éšããããåæã®è°è«ã§äžå¿ç圹å²ãæããããã峿 Œãªçç©å®å šèŠå¶ãæ¯æããç§åŠè ããç§çã«æ¹å€ããŠããããšã瀺ããŠããã
æ©èœç²åŸç ç©¶ã¯ããŠã€ã«ã¹ã®äŒææ§ãæ¯æ§ãé«ãããã®ã§ãSARS-CoV-2ã®åµåºã«ã€ãªãã£ãå¯èœæ§ãææãããŠãããäžæ¹ã§ã¯ã¯ãã³éçºã§ãäžè¬çã«çšãããããé£éŠæ¿åºã¯2014幎ãã2017幎ã«ãããŠãæ©èœç²åŸç ç©¶ãžã®è³éæäŸãäžæåæ¢ããã
2021幎9æãNIHã®å©æãå埩ããåŸã«ãã¶ãã¯ãžéã£ãã¡ãŒã«ã§ãã¢ãŒã¬ã³ã¹ã¯èªåïŒã¢ãŒã¬ã³ã¹ïŒã«ãããã¯ããã¯ãã¯å ¥ãã®ããšå°ããããã©ãã¯ã¹ã»ãã¥ãŒã¹ã«ããã°ãã¢ãŒã¬ã³ã¹ã¯2024幎ã®è°äŒèšŒèšã§ããããã®ã¡ãã»ãŒãžã¯ããã©ãã¯ãŠãŒã¢ã¢ãã ã£ããšè¿°ã¹ãéä¿¡ããäžéšã¡ãŒã«ã®æé¢ãåŸæããŠãããšèªã£ãã
ã起蚎ã¯â巚倧ãªå¢å Žã®éªžéªšã®å±±âãæããã«ããäžæ©ã«ãªããããããªãã
2025幎1æãéä»»ã®éäžã«ãã£ããžã§ãŒã»ãã€ãã³å倧統é ã¯ããã¡ãŠãæ°ã2014幎ãŸã§é¡ã£ãŠè¡ã£ãå ¬åã«é¢ããŠããããããæ©èµŠãäžããã
æ©èµŠããã£ãã«ãããããããæ³æ¹ã®å°éå®¶ãã¯ããã¡ãŠãæ°ãå·ã¬ãã«ã®èšŽè¿œã«çŽé¢ããå¯èœæ§ãäŸç¶ãšããŠãããè°äŒèšŒèšã®ããã«å¬åç¶ãåããå¯èœæ§ãæ®ã£ãŠãããšç€ºåããŠããã
2025幎7æãã©ã³ãã»ããŒã«äžé¢è°å¡ïŒå ±åã»ã±ã³ã¿ãããŒïŒã¯ãæ°åã³ããã®èµ·æºã«é¢ããåè°å¡ã®è°äŒèª¿æ»ã®äžç°ãšããŠããã¡ãŠãæ°ã宣èªã®äžã§èšŒèšã匷ããããå¯èœæ§ããããšç€ºåããã
2025幎9æãããŒã«æ°ã¯ã2020幎ã®è€æ°ã®é»åã¡ãŒã«ãå ¬éããåŸããã¡ãŠãæ°ãè°äŒèšŒèšã«æèŽãããå ¬éãããã¡ãŒã«ã§ã¯ããã¡ãŠãæ°ãååã«ã¡ãã»ãŒãžã®åé€ãæç€ºããŠããããšã瀺ãããŠãããã¡ãŒã«ã¯ãŸãããã³ãããã¯åæã«ããã¡ãŠãæ°ãä»ã®å ¬è¡è¡çåœå±è ããç§åŠãšç©èªïŒãã©ãã£ãïŒã«å åããããããšããŠããããšã瀺ããŠããã
æšå¹Žããã©ã³ãæ¿æš©ã¯ãåŠè¡èªãNature Medicineãã®åºç瀟ã«å¯Ÿãã調æ»ãéå§ããã2020幎3æãåèªã¯è€æ°ã®ãŠã€ã«ã¹åŠè ãå ±èãïŒãã¡ãŠãæ°ã®å©èšãåæ ïŒãæ°åã³ãããŠã€ã«ã¹ïŒSARS-CoV-2ïŒã¯èªç¶çã«ç±æ¥ããŠé²åãããšçµè«ã¥ããè«æãThe proximal origin of SARS-CoV-2ïŒSARS-CoV-2ã®è¿æ¥èµ·æºïŒããæ²èŒããã
ããããã·ãã«ã»ãªãªãžã³ãè«æã¯âããããæ¬æ¥ã®èµ·èšŽç¶ã§èšåããããã®âãSARS-CoV-2ãç ç©¶æããæŒãããããšããçè«ã®æšé²è ãã¡ã®ä¿¡çšãå·ã€ããã®ã«å¯äžãããç§åŠè ãæ¿åºåœå±ãã¡ãã£ã¢å瀟ã¯ãã®è«æãåºãåŒçšããç ç©¶ææµåºèª¬ã®æšé²è ãé°è¬è«è ãšäœçœ®ã¥ããææãšããã
ãã©ãŠã³ã¹ããŒã³ç ç©¶æã®åµèšè ã»ä»£è¡šã®ãžã§ããªãŒã»ã¿ãã«ãŒæ°ã¯ã2020幎ã«ã¢ã¬ã³ãºæ°ãšãã¡ãŠãæ°ãå¥ã®è«æãå ±èããSARS-CoV-2ãèªç¶èµ·æºãšãããäžé£ã®ãã³ãããã¯ã®ææ°äŸãšããŠäœçœ®ã¥ãããšè¿°ã¹ããCellèªã«æ²èŒããããã®è«æã¯ãè€æ°ã®äººéã®è¡åãæŽ»åãCOVID-19ã®æ¡å€§ã«å¯äžããå¯èœæ§ã瀺åããŠããã
ã圌ãã¯ç€ŸäŒã®ã€ã³ãã©ãäœãå€ãããœãŒã·ã£ã«ã»ãã£ã¹ã¿ã³ã·ã³ã°ãçæŽ»ã®æä¹ çãªèŠçŽ ã«ãããã£ãŠããããšã¿ãã«ãŒæ°ã¯èªã£ãããèŠããã«ããã®è«æã¯æ£æ°ã®æ²æ±°ã§ã¯ãªããåœæã®NIH/NIAIDã§ã©ãã»ã©å€ãã®ããšãééã£ãŠããããé²åããŠããã巚倧ãªâ骞骚ã®ã¯ããŒãŒããâããããããã¯ãã®äžã®å°ããªéªšã®äžæ¬ã«éããªããã
æšå¹Žããã©ã³ãæ¿æš©ã¯æ¿åºã®å ¬åŒCOVID-19ãµã€ãã®æ°ããŒãžã§ã³ãç«ã¡äžããæŠæŒ¢ã®ç ç©¶æããã®æŒããã«ãã£ãŠCOVID-19ãçºçããããšã瀺ã蚌æ ãæç€ºããã
CIAãFBIãç±³ãšãã«ã®ãŒçãé£éŠè°äŒãããã³äžéšã®æµ·å€æ å ±æ©é¢ã¯ãç ç©¶ææµåºèª¬ãæ¯æããŠããã
ãã¢ã¬ã³ãºã¯ã²ãŒãããŒããŒã ã£ãããšã°ã¬ã€ã¶ãŒæ°ã¯èªã£ãããæ¬åœã®èª¬æè²¬ä»»ãšã¯ããããã®æ¿çã®èšèšè ãäŸãã°å ¬æµãã³ããŒã¯ã³ã®ãã¡ãŠãã®ãããªäººç©ãèŠãããšãæå³ãããäžé¢ã®èª¿æ»ã®ã¿ã€ãã³ã°ã¯éèŠã§ãããä»åã®èµ·èšŽã¯ãNIAIDäžå±€éšã®å®æ ãæŽãããšããããŒã«äžé¢è°å¡ã®åãçµã¿ããã£ããåŸæŒãããã¯ãã ãã
ãCOVIDãåŒãèµ·ããããã®åå ãé èœãã人ã ã«å¯Ÿãã起蚎ã»èšŽè¿œã»æçœªå€æ±ºã¯ãç¶æ³ãåããã ããããšãšã€ãã©ã€ãæ°ã¯è¿°ã¹ããã説æè²¬ä»»ããªããã°ãç¡è¬ããšåã¯ãããããç¶ãã ãããã